Does oral semaglutide work? Yes, and large clinical trials have confirmed its effectiveness. Researchers tested this medication in controlled studies involving adults with overweight or obesity, and participants taking oral semaglutide lost significantly more weight than those who did not receive the medication.
Because of these results, regulators reviewed the data and granted FDA approval, confirming that oral semaglutide is a recognized medical treatment rather than an experimental option.
Even so, many people still want to see the actual proof before deciding whether this approach makes sense for them. They often ask practical questions:
- How much weight did people really lose?
- How long did those results last?
- And what findings convinced experts that this medication works?
To answer those questions, we’ll focus on the key clinical findings and approval milestones that explain how and why oral semaglutide delivers measurable results.
Key Takeaways
- Clinical trials showed an average weight loss of about 13.6% with oral semaglutide, compared to about 2.2% with placebo.
- Many participants achieved key milestones, including 5%, 10%, and 15% or more total body weight loss.
- Weight loss was maintained across studies lasting more than one year.
- Researchers also observed improvements in physical function beyond weight loss alone.
- FDA approval followed review of these results, confirming oral semaglutide as a recognized medical treatment.
1. Oral Semaglutide Led to an Average 13.6% Weight Loss in a Major Clinical Trial
In the OASIS 4 clinical trial, published in the New England Journal of Medicine, researchers studied adults with overweight or obesity who took oral semaglutide daily for 64 weeks.
Participants taking oral semaglutide lost an average of about 13.6% of their body weight, compared to about 2.2% in those taking placebo. This difference showed that the medication produced meaningful weight loss beyond lifestyle changes alone.
Because weight loss above 10% is widely considered clinically meaningful, these results help answer an important question — does oral semaglutide work? Based on these findings, the data shows that it can support sustained and measurable weight reduction over time.
2. Many Participants Achieved 5% to 15% Weight Loss Milestones
In the same study, researchers also tracked how many people reached specific weight loss targets. Many participants taking oral semaglutide achieved 5%, 10%, and even 15% or more weight loss during the study period.
These milestones matter because even 5% weight loss can improve blood sugar, blood pressure, and overall metabolic health. As weight loss reaches 10% to 15%, many individuals begin to notice more meaningful changes in energy levels, movement, and daily health.
Overall, these results show that oral semaglutide helped many participants reach meaningful weight loss levels — not just small changes.
Seeing What the Research Shows?
3. Weight Loss Continued Over 64 Weeks in the Same Clinical Study
Over the course of the study, researchers followed participants for 64 weeks, which is a little more than one year. During this time, individuals taking oral semaglutide continued to lose weight and maintain their progress rather than regaining weight quickly.
This longer study period matters because short-term weight loss can sometimes fade over time. In contrast, results that continue for a full year show that oral semaglutide supported sustained weight loss, not just temporary changes.
These long-term results provide another clear reason why many clinicians view the data as strong evidence when evaluating does oral semaglutide work in real-world settings.
4. Results Were Consistent Across Different Groups of Participants
Researchers also looked at whether the results varied across different types of participants. They compared outcomes across groups based on body weight, sex, race, and ethnicity to see if certain populations responded differently.
The findings showed that weight loss results remained consistent across different groups, meaning the medication worked similarly across a wide range of participants. This consistency helped strengthen confidence in oral semaglutide as an option that can support weight loss in diverse populations.
These results matter because treatments that work across many groups are more likely to produce reliable outcomes in real-world settings.
5. Oral Semaglutide Received FDA Approval After Review of Clinical Results
After reviewing the clinical trial data, the FDA approved oral semaglutide as a treatment option for weight management. This approval followed the results of large studies that showed consistent and meaningful weight loss in adults with overweight or obesity.
The approval also marked an important milestone — oral semaglutide became the first oral GLP-1 medication approved for weight loss, offering a daily pill option for individuals who prefer an alternative to injections.
FDA approval matters because it confirms that experts carefully reviewed both safety and effectiveness before allowing the medication to be used in medical practice. Taken together with the clinical trial results, this approval provides strong supporting evidence when evaluating does oral semaglutide work as a medically guided treatment.
Final Thoughts
As the clinical studies have shown, oral semaglutide produced meaningful weight loss across large groups of participants and maintained results over more than one year. Many individuals reached clinically important weight loss milestones, and regulators approved the medication after carefully reviewing its safety and effectiveness.
Taken together, these findings make it reasonable to conclude that oral semaglutide works as a medically supported option for weight management when used under proper guidance.
Ready to Take Control of Your Weight With a Proven Approach?
Oral semaglutide offers a convenient daily option designed to support consistent progress with medical oversight.
Frequently Asked Questions
Yes. Large clinical trials showed that people taking oral semaglutide lost significantly more weight than those taking placebo. In one major study published in the New England Journal of Medicine, participants lost an average of about 13.6% of their body weight, confirming that the medication can support meaningful weight reduction.
Yes. The FDA approved oral semaglutide after reviewing large clinical trials that demonstrated both safety and effectiveness. It also became the first oral GLP-1 medication approved for weight loss, offering a daily pill alternative to injectable options.
Both oral and injectable semaglutide are designed to support weight loss and appetite control. While injectable forms may deliver higher doses in some cases, research shows that oral semaglutide can still produce meaningful weight loss when taken consistently under medical supervision.
